Cargando…
Erenumab versus topiramate: post hoc efficacy analysis from the HER-MES study
OBJECTIVE: HER-MES was the first head-to-head, phase 4 trial to assess the tolerability and effectiveness of erenumab against standard of care treatment (topiramate). This post hoc analysis compared the efficacy of erenumab with topiramate in patients who completed the trial on study medication. MET...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Milan
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664641/ https://www.ncbi.nlm.nih.gov/pubmed/36380284 http://dx.doi.org/10.1186/s10194-022-01511-y |